7 results
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
the mainstay of VTE ... . heparin, LMWH, ... . rivaroxaban) is ... - Rivaroxaban ... #LMWH #UFH #DOAC
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
PCC (Kcentra) - Heparin ... /LMWH → Protamine ... Edoxaban (Lixiana), Rivaroxaban ... anticoagulation #doac ... #noac #pharmacology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
, edoxaban and rivaroxaban ... anticoagulant; LMWH ... molecular weight heparin ... body mass index; VTE ... #DOAC #VTE #Malignancy
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
clotting #INR #heparin ... #LMWH #NOAC #warfarin ... #coumadin #rivaroxaban
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... (LMWH) - Enoxaparin ... inhibitors - Apixaban, rivaroxaban ... #medications #doac
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE ... risk of recurrent VTE ... DOAC, direct oral ... low-molecular-weight heparin ... #DOAC #VTE #Malignancy
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
Malabsorption (e.g ... Medications - Heparin ... , LMWH, warfarin ... , DOACs (e.g. direct ... Autoimmune disorders (e.g